Humana AB (publ) (HUM.ST)
SEK 41.05
(0.49%)
SEK 41.05
(0.49%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.66 Billion SEK | -6.65% |
| 2022 | 4.99 Billion SEK | 6.21% |
| 2021 | 4.7 Billion SEK | 36.04% |
| 2020 | 3.45 Billion SEK | -5.83% |
| 2019 | 3.67 Billion SEK | 191.58% |
| 2018 | 1.25 Billion SEK | -6.39% |
| 2017 | 1.34 Billion SEK | -4.34% |
| 2016 | 1.4 Billion SEK | -9.29% |
| 2015 | 1.55 Billion SEK | -6.4% |
| 2014 | 1.65 Billion SEK | 206.67% |
| 2013 | 540 Million SEK | 11.24% |
| 2012 | 485.43 Million SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.98 Billion SEK | -2.41% |
| 2024 Q3 | 1.9 Billion SEK | -4.12% |
| 2024 Q1 | 2.03 Billion SEK | 16.07% |
| 2023 Q2 | 5.26 Billion SEK | 3.4% |
| 2023 Q1 | 5.09 Billion SEK | 2.0% |
| 2023 Q4 | 1.75 Billion SEK | -61.12% |
| 2023 FY | 1.75 Billion SEK | -64.86% |
| 2023 Q3 | 4.51 Billion SEK | -14.31% |
| 2022 Q3 | 4.89 Billion SEK | 3.05% |
| 2022 FY | 4.99 Billion SEK | 6.21% |
| 2022 Q1 | 4.72 Billion SEK | 0.38% |
| 2022 Q2 | 4.75 Billion SEK | 0.68% |
| 2022 Q4 | 4.99 Billion SEK | 1.98% |
| 2021 FY | 4.7 Billion SEK | 36.04% |
| 2021 Q2 | 2.32 Billion SEK | 17.97% |
| 2021 Q3 | 4.57 Billion SEK | 96.73% |
| 2021 Q1 | 1.97 Billion SEK | -43.01% |
| 2021 Q4 | 4.7 Billion SEK | 2.87% |
| 2020 FY | 3.45 Billion SEK | -5.83% |
| 2020 Q2 | 3.68 Billion SEK | -0.38% |
| 2020 Q3 | 3.68 Billion SEK | 0.03% |
| 2020 Q4 | 3.45 Billion SEK | -6.11% |
| 2020 Q1 | 3.69 Billion SEK | 0.65% |
| 2019 Q3 | 3.66 Billion SEK | 4.87% |
| 2019 FY | 3.67 Billion SEK | 191.58% |
| 2019 Q4 | 3.67 Billion SEK | 0.19% |
| 2019 Q2 | 3.49 Billion SEK | 38.49% |
| 2019 Q1 | 2.52 Billion SEK | 100.4% |
| 2018 Q4 | 1.25 Billion SEK | -1.72% |
| 2018 FY | 1.25 Billion SEK | -6.39% |
| 2018 Q1 | 1.3 Billion SEK | -2.9% |
| 2018 Q2 | 1.28 Billion SEK | -1.53% |
| 2018 Q3 | 1.28 Billion SEK | -0.39% |
| 2017 Q1 | 1.36 Billion SEK | -2.92% |
| 2017 Q2 | 1.35 Billion SEK | -1.1% |
| 2017 Q4 | 1.34 Billion SEK | -0.44% |
| 2017 Q3 | 1.35 Billion SEK | 0.07% |
| 2017 FY | 1.34 Billion SEK | -4.34% |
| 2016 Q3 | 1.4 Billion SEK | 1.01% |
| 2016 Q2 | 1.39 Billion SEK | 1.31% |
| 2016 FY | 1.4 Billion SEK | -9.29% |
| 2016 Q4 | 1.4 Billion SEK | 0.0% |
| 2016 Q1 | 1.37 Billion SEK | -11.35% |
| 2015 FY | 1.55 Billion SEK | -6.4% |
| 2015 Q4 | 1.55 Billion SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2014 FY | 1.65 Billion SEK | 206.67% |
| 2013 FY | 540 Million SEK | 11.24% |
| 2012 FY | 485.43 Million SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Ambea AB (publ) | 1.42 Billion SEK | -227.688% |
| Attendo AB (publ) | 2.07 Billion SEK | -124.94% |
| ProstaLund AB (publ) | 933 Thousand SEK | -499685.638% |